Parallel Bio relocates to Bay Area with $30M to replace animal drug testing with organoids
By
Ron Leuty
Summary
Parallel Bio, a biotech startup co-founded by Robert DiFazio and Juliana Hilliard, has relocated from Boston to the Bay Area after raising $30 million. The company aims to end animal testing for drugs by using organoids — lab-grown miniature organs — to test pharmaceutical compounds. Their high-tech approach represents a shift toward more ethical and potentially more accurate drug testing methods.
Source
bskyParallel Bio relocates to Bay Area with $30M to replace animal drug testing with organoidsbizjournals.comKey quotes
· 1 pulledThis company returned to the Bay Area on a high-tech mission: End animal testing for drugs
You might also wanna read
Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·26d agoStartup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·26d ago
BIOS AI Platform for Biomedical Research Ranks #1 on BixBench Benchmark
BIOS is an AI-powered scientific research platform that ranked #1 on BixBench for biological data analysis. The system offers flexible resea
Product Hunt·4mo ago
Biohub launches $500M Virtual Biology Initiative to build predictive models of human cells
Biohub has announced the Virtual Biology Initiative, a $500 million, five-year global effort to develop technologies and multi-modal dataset
Biohub·1mo ago
Frontier Bio develops engineered blood vessels as foundation for lab-grown organs
Frontier Bio is developing tissue-engineered blood vessels (vascular grafts) and in-vitro tissue platforms, aiming to address the global org
frontierbio.com·1d ago
Alp Bio's AI platform predicts immune reactions to biologic drugs in early development
An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i
Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge Genomics, an AI drug discovery company, is hiring for multiple engineering and product roles including Head of Product & Engineering,
news.ycombinator.com·8mo agoComments
Sign in to join the conversation.
No comments yet. Be the first.